Ophthalmic compositions comprising povidone-iodine
US7767217B2 · kind B2 · utility
9Cited by
14References
21Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Dec 7, 2006 |
| Grant date | Aug 3, 2010 |
| Priority date | — |
| Expiry date | Jan 13, 2027 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY02A50/30
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A topical ophthalmic composition comprised of povidone-iodine 0.01% to 10.0% combined with a steroid or non-steroidal anti-inflammatory drug. This solution is useful in the treatment of active infections of at least one tissue of the eye (e.g., conjunctiva and cornea) from bacterial, mycobacterial, viral, fungal, or amoebic causes, as well as treatment to prevent such infections in appropriate clinical settings (e.g. corneal abrasion, postoperative prophylaxis, post-LASIK/LASEK prophylaxis). Additionally the solution is effective in the prevention of infection and inflammation in the post-operative ophthalmic patient.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.